Biovariability of plasma adiponectin

Area of Science:

• Endocrinology
• Metabolic Syndrome Research
• Clinical Biochemistry

Background:

• Adiponectin, a cytokine from adipose tissue, possesses insulin-sensitizing and anti-atherosclerotic properties.
• Low plasma adiponectin is a recognized indicator of metabolic syndrome and emerging type 2 diabetes.

Purpose of the Study:

• To assess the short- and long-term variability of plasma adiponectin levels.
• To investigate diurnal and post-prandial fluctuations in adiponectin.
• To evaluate the impact of frozen storage on adiponectin stability.

Main Methods:

• Variability assessment over 30 days and 15 months in overweight and non-obese subjects.
• Analysis of diurnal and post-prandial adiponectin changes.
• Evaluation of assay variability and effect of long-term frozen storage (-30°C for 33 months) and freeze-thaw cycles.

Main Results:

• Intra-subject variation over 30 days was 12.2% (metabolic syndrome) and 18.8% (controls).
• Plasma adiponectin levels demonstrated minimal variation over 15 months in non-obese subjects (8.3 vs. 8.2 µg/mL).
• Diurnal and post-prandial changes were minor, with assay variation at 8.8%; frozen storage and freeze-thaw cycles did not affect levels.

Conclusions:

• Plasma adiponectin exhibits low biovariability.
• Adiponectin can be reliably measured in fasting or non-fasting states.
• It serves as a dependable biomarker for insulin resistance and early-stage type 2 diabetes.